Gene · 6582
Papers2,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cellular and Functional Biomarkers of Renal Injury and Disease. | Curr Opin Toxicol | 2022 | 36540379 | PubTator, text mining | PubMed |
| Pharmacogenetics of chemotherapy treatment response and -toxicities in patients with osteosarcoma: a systematic review. | BMC Cancer | 2022 | 36536332 | PubTator, text mining | PubMed |
| Serotonin system in the human placenta - the knowns and unknowns. | Front Endocrinol (Lausanne) | 2022 | 36531448 | PubTator, text mining | PubMed |
| Diabetes mellitus degenerates cisplatin-induced nephrotoxicity in short hydration method: a propensity score-matching analysis. | Sci Rep | 2022 | 36528725 | PubTator, text mining | PubMed |
| The copper transporter CTR1 and cisplatin accumulation at the single-cell level by LA-ICP-TOFMS. | Front Mol Biosci | 2022 | 36518851 | PubTator, text mining | PubMed |
| Quality assessment and refinement of chromatin accessibility data using a sequence-based predictive model. | Proc Natl Acad Sci U S A | 2022 | 36508674 | PubTator, text mining | PubMed |
| Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neurotoxicity. | Cancer Res Commun | 2022 | 36506732 | PubTator, text mining | PubMed |
Metals-triggered compound CDPDP exhibits anti-arthritic behavior by downregulating the inflammatory cytokines, and modulating the oxidative storm in mice models with extensive ADMET, docking and simulation studies. | Front Pharmacol | 2022 | 36506587 | PubTator, text mining | PubMed |
| Modelling of p-tyramine transport across human intestinal epithelial cells predicts the presence of additional transporters. | Front Physiol | 2022 | 36505075 | PubTator, text mining | PubMed |
| Revisiting the Anti-Cancer Toxicity of Clinically Approved Platinating Derivatives. | Int J Mol Sci | 2022 | 36499737 | PubTator, text mining | PubMed |
| TRPML2 Mucolipin Channels Drive the Response of Glioma Stem Cells to Temozolomide and Affect the Overall Survival in Glioblastoma Patients. | Int J Mol Sci | 2022 | 36499683 | PubTator, text mining | PubMed |
| Enalapril increases the urinary excretion of metformin in rats by inducing multidrug and toxin excretion protein 1 in the kidney. | Biopharm Drug Dispos | 2022 | 36494876 | PubTator, text mining | PubMed |
| Loss of the volume-regulated anion channel components LRRC8A and LRRC8D limits platinum drug efficacy. | Cancer Res Commun | 2022 | 36467895 | PubTator, text mining | PubMed |
| Increased amisulpride serum concentration in a patient treated with concomitant pregabalin and trazodone: a case report. | Ther Adv Psychopharmacol | 2022 | 36465957 | PubTator, text mining | PubMed |
| Genomic imprinting in human placentation. | Reprod Med Biol | 2022 | 36465588 | PubTator, text mining | PubMed |
| Computational study of nitro-benzylidene phenazine as dengue virus-2 NS2B-NS3 protease inhibitor. | Front Mol Biosci | 2022 | 36465554 | PubTator, text mining | PubMed |
| SLC22A3 methylation-mediated gene silencing predicts adverse prognosis in acute myeloid leukemia. | Clin Epigenetics | 2022 | 36461046 | PubTator, text mining | PubMed |
| Increased copy number of imprinted genes in the chromosomal region 20q11-q13.32 is associated with resistance to antitumor agents in cancer cell lines. | Clin Epigenetics | 2022 | 36461044 | PubTator, text mining | PubMed |
| Lipoprotein(a) and Cardiovascular Disease in Chinese Population: A Beijing Heart Society Expert Scientific Statement. | JACC Asia | 2022 | 36444328 | PubTator, text mining | PubMed |
| SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin. | Front Pharmacol | 2022 | 36438828 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6582/papers?page=20